TGFB1 and fibrosis: PegHYAL was reduced the concentration of TNF-α (to 1.3%), IL-1β (to 72%), TGF-β1 (to 12.5%) in serum and TGF-β (to 11%) in BLM-injured lung compared to untreated mice with fibrosis (S1 Fig).